QQ客服 官方微博 反馈留言

	A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
	Zhang, L.; Lu, S.; Feng, J.; Dechaphunkul, A.; Chang, J.; Wang, D.; Chessari, S.; Lanzarotti, C.; Jordan, K.; Aapro, M.
刊名	ANNALS OF ONCOLOGY
	2018
卷号	29期号:2
关键词	CINV netupitant palonosetron NEPA aprepitant
ISSN号	0923-7534
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3600256
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, L.,Lu, S.,Feng, J.,et al. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)[J]. ANNALS OF ONCOLOGY,2018,29(2).
APA	Zhang, L..,Lu, S..,Feng, J..,Dechaphunkul, A..,Chang, J..,...&Aapro, M..(2018).A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).ANNALS OF ONCOLOGY,29(2).
MLA	Zhang, L.,et al."A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)".ANNALS OF ONCOLOGY 29.2(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。